Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,400.00
Bid: 12,398.00
Ask: 12,400.00
Change: 2.00 (0.02%)
Spread: 2.00 (0.016%)
Open: 12,432.00
High: 12,482.00
Low: 12,318.00
Prev. Close: 12,398.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

GLOBAL MARKETS-Shares lifted to record highs by lockdown easing, benign Fed

Thu, 08th Apr 2021 10:52

* Europe's STOXX index up 0.3%

* S&P futures reach another peak, Nikkei lags

* Asian stock markets : https://tmsnrt.rs/2zpUAr4

* Fed sticking to stimulus, Powell set to speak

* Treasury yields dip, leaving dollar aimless

By Huw Jones

LONDON, April 8 (Reuters) - Stocks in Europe reached record
highs on Thursday, buoyed by optimism in Britain over easing
lockdown restrictions, while a benign outlook for U.S. interest
rates was set to push Wall Street to new heights.

The European STOXX index of leading 600 companies
rose 0.3%, hitting a new high of 436.66 points. London's blue
chip FTSE 100 index was up 0.2%.

"It's looking good as evaluations in Europe are much lower
than they are in the U.S. so there is potentially more upside.
The line of least resistance for European markets is higher,"
said Michael Hewson, chief market analyst at CMC Markets.

"In terms of economic re-opening, there is enough optimism
built in at the moment to drive markets quite a bit higher from
here, and the Fed has reiterated it's going to remain on hold
for a while," Hewson said.

Minutes of the Federal Reserve's last policy meeting,
published on Wednesday, showed members felt the economy was
still far short of target and were in no rush to scale back
their $120 billion a month of bond buying.

Fed Chairman Jerome Powell speaks at an International
Monetary Fund event later on Thursday and is likely to reiterate
the dovish outlook.

The European Central Bank was due to publish accounts for
its March 11 policy meeting amid debate about when it should
start tapering its pandemic stimulus, with the euro area
recovery still in doubt.

Wall Street was also set to reach fresh peaks on Thursday
with e-mini futures on the S&P 500 rising 0.25% after
rising to a record high, and Nasdaq futures up 0.7%

Gains by U.S. Treasuries also helped, although
analysts said markets will be tested next week when the U.S.
earnings seasons gets underway.

In Asia, MSCI's broadest index of Asia-Pacific shares
outside Japan inched up 0.3% in quiet trade.
Japan's Nikkei slipped 0.3%, not helped by news Tokyo's
governor had asked for emergency measures to stem a surge of
COVID-19 infections.

Yields on 10-year Treasuries have eased back
to 1.669% from the recent 14-month high of 1.776%, but have
struggled to break under 1.59%.

The decline coincided with a dip in the dollar index to
92.360 from its recent five-month high at 93.439.

The euro was steady at $1.1871, after rising as high
as $1.1914 overnight following a surprisingly upbeat survey of
European Union business activity.

In commodity markets, gold was at $1,743 an ounce
after meeting resistance around $1,745.

Oil prices fell after official figures showed a big
increase in U.S. gasoline stockpiles, causing concerns about
demand for crude weakening in the world's biggest consumer of
the resource at a time when supplies around the world are
rising.

Brent fell 22 cents to $62.94 a barrel. U.S. crude
lost 37 cents to $59.40 per barrel.

(Aditional reporting by Wayne Cole and Chibuike Oguh; editing
by Larry King)

More News
2 Apr 2024 09:54

LONDON BROKER RATINGS: Bernstein starts AstraZeneca at 'outperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
2 Apr 2024 09:09

LONDON MARKET OPEN: FTSE 100 up as oil majors and gold miners shine

(Alliance News) - Stock prices in London opened higher on Tuesday, in confident trade following the long Easter weekend, ahead of a UK manufacturing sector reading later in the morning.

Read more
2 Apr 2024 08:05

LONDON BRIEFING: HSBC in special payout on Canada sale; Astra FDA win

(Alliance News) - London's FTSE 100 traded higher on Tuesday following the long weekend, as investors react to US data, and look ahead to manufacturing sector readings from Europe later.

Read more
2 Apr 2024 07:08

US FDA gives green light for use of AstraZeneca's Voydeva

(Sharecast News) - America's drug regulator gave the green light to AstraZeneca's for the add-on use of Voydeya in the treatment of extravascular haemolysis (EVH) in patients with paroxysmal nocturnal haemoglobinuria (PNH).

Read more
27 Mar 2024 12:02

LONDON MARKET MIDDAY: FTSE 100 underperforms ahead of US PCE data

(Alliance News) - Stock prices in London were lower at midday on Wednesday, but trade was more confident in mainland Europe, with focus turning to the release of the US Federal Reserve's preferred inflation gauge on Friday.

Read more
27 Mar 2024 11:56

C4X Discovery seeks AIM delisting but half-year revenue skyrockets

(Alliance News) - C4X Discovery Holdings PLC shares plunged on Wednesday after it said it plans to delist from AIM in London, due to "the recent downturn in the financial markets" hampering its valuation.

Read more
27 Mar 2024 09:19

AstraZeneca treatments become "first and only" to be approved in Japan

(Alliance News) - AstraZeneca PLC announced on Wednesday the approval of two of its treatments for use in Japan.

Read more
27 Mar 2024 09:03

LONDON MARKET OPEN: FTSE 100 slips as unease lingers before US data

(Alliance News) - Stock prices in London edged lower after the open on Wednesday, with some nervy trade ahead of a US inflation reading later in the week.

Read more
27 Mar 2024 08:02

LONDON BRIEFING: Diploma makes buy; Astra wins Japan drug approvals

(Alliance News) - Stocks in London opened in a muted fashion on Wednesday, with some unease lingering in equity markets ahead of a US inflation reading later in the week.

Read more
26 Mar 2024 10:18

China to speed up 'new productive forces', vice president says

BEIJING, March 26 (Reuters) - China will accelerate the development of "new productive forces" and bolster stability and security for the global economy, Vice President Han Zheng told an investment forum in Beijing, as the world's no.2 economy seeks to reassure anxious foreign firms.

Read more
25 Mar 2024 12:09

LONDON MARKET MIDDAY: Stocks make tepid start to new week

(Alliance News) - Stock prices in London were down at midday on Monday, giving back some gains from last week, when equities were boosted by central bank decisions and accompanying statements which investors saw as dovish.

Read more
25 Mar 2024 09:04

LONDON MARKET OPEN: FTSE 100 treads water, FTSE 250 declines

(Alliance News) - The FTSE 100 in London traded flat early Monday, while the pound remained below the USD1.26 mark, as Bank of England Governor Andrew Bailey suggested rate cuts may happen soon.

Read more
25 Mar 2024 08:40

TOP NEWS: AstraZeneca wins US approval for rare nervous system disease

(Alliance News) - AstraZeneca PLC on Monday said its Ultomiris treatment has been approved by the US Food & Drug Administration as the first and only long-acting C5 complement inhibitor to treat neuromyelitis optica spectrum disorder in adults.

Read more
25 Mar 2024 07:59

LONDON BRIEFING: AstraZeneca wins US approval, Kingfisher profit down

(Alliance News) - London's FTSE 100 is set to open lower on Monday, giving back some of last week's progress, when equities were boosted by hope of interest rate cuts.

Read more
25 Mar 2024 07:23

AstraZeneca gets FDA approval for Ultomiris treatment

(Sharecast News) - AstraZeneca has announced that its autoimmune disease treatment Ultomiris has been given the green light by US regulators.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.